Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Boyd ST et al. – Diabetes patients with metabolic syndrome are prescribed multiple drug therapies to control diabetes and other metabolic abnormalities. In this study, the authors concluded that the average pill burden was 13.1 in patients with glucose–controlled diabetes and metabolic syndrome.

Related Articles

ADAMTS13 and von Willebrand factor concentrations in patients with diabetes mellitus
Blood Coagulation & Fibrinolysis, 11/03/09    Relevance Score: 71%

Hepatic fat and inflammation in type 2 diabetes mellitus
Metabolism-Clinical and Experimental, 10/26/09    Relevance Score: 70%

Measurement of cerebral oxidative glucose consumption in patients with type 1 diabetes mellitus and hypoglycemia unawareness using 13C nuclear magnetic resonance spectroscopy
Metabolism-Clinical and Experimental, 10/13/09    Relevance Score: 70%

Menstrual cycle irregularities and their relationship with HbA1c and insulin dose in adolescents with type 1 diabetes mellitus
Fertility and Sterility, 10/08/09    Relevance Score: 70%

So Just What Can I Eat? Nutritional Care in Patients with Diabetes Mellitus and Chronic Kidney Disease
Nephrology Nursing Journal, 10/06/09    Relevance Score: 70%

Today in Other Drugs...keeping you current

New central targets for the treatment of obesity
British Journal of Clinical Pharmacology, 12/11/09

Metformin increases plasma ghrelin in Type 2 diabetes
British Journal of Clinical Pharmacology, 12/11/09

Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation
Core Evidence, 12/11/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address